Chemoradiation therapy after endoscopic resection for rectal carcinoma

Chemoradiation therapy after endoscopic resection for rectal carcinoma - CRT after EMR for rectal carcinoma

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007415

Enrollment

Registered

2012-03-01

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal carcinoma

Interventions

We study alternate treatment for rectal cancer which was resected endoscopically. TS-1 and radiation(total 45Gy) are replaced by the administration of surgical operation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.rectal carcinoma(Rb) 2.lesion was resected by endoscopically. 3.indication of radical surgical resection 4.no metastasis in kickoff point 5.tolerable condition for chemoradiation 6.give informed consent

Exclusion criteria

Exclusion criteria: 1.not satisfy selection criteria 2.drug allergy

Design outcomes

Primary

Measure	Time frame
rate of recurrence and suuvival time	—

Secondary

Measure	Time frame
1)pathological findings of SM carcinoma 2)total dose of TS-1 3)total dose of radiation 4)site of recurrence, type of recurrence 5)survival rate, disease-free survival 6)adverse event	—

Countries

Japan

Contacts

Public ContactYuichi Tomiki

Juntendo University Department of Coloproctological Surgery

tomiki@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026